Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC

Clinical trial NCT07400094 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07400094
Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck Laryngeal Neoplasms Oral Cavity Neoplasm

Start date: 2026-02-01
Primary completion: 2029-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.